{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T12:32:12Z","timestamp":1723120332215},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The first systematic review and meta-analysis to help clinician to identify early signs and symptoms of neurological manifestation in COVID-19 positive patients which will further help in early management of patients. Present systematic review and meta-analysis aimed to discuss the prevalence of neurological involvement of the 2019-nCoV patients and assess the symptomatic trend of events as compared to the 2002 \u201cSARS\u201d and 2012 \u201cMERS\u201d pandemics.\nThe articles were systematically screened through several search engine and databases. The articles published or in preprint were included in the study till 15th May 2020. The systematic review done as per the published literatures which included 31 cross sectional, observational studies and case reports which revealed neurological signs and symptoms in SARS-COV-2 disease. For meta-analysis, we included 09 observational and cross-sectional studies which included COVID-19 positive patients and assessed the predominance of various neurological signs and symptoms in COVID-19 patients with relation to SARS-2002 and MERS-2012. Data was analyzed by using the \u201c<jats:italic>MedCalc<\/jats:italic>\u201d Statistical Software version 19.2.6 and reported as pooled prevalence. Standard I<jats:sup>2<\/jats:sup> test was used to analyze the heterogeneity. We have collected and screened about a total 2615articles, finally we have included 31articles for the systematic review and 09 for meta-analysis as per the inclusion\/exclusion criteria. The analysis was made as per the prevalence rate of neurological symptoms in COVID-19 positive patients. The cumulative neurological outcome of SARS-2002 and MERS-2012 was assessed to get the trends which was further tried to correlate the events with the current pandemic. During the analysis severity and outcome of neurological manifestations range from simple headache to vague non-focal complaints to severe neurologic impairment associated with seizure or meningitis. Central and peripheral nervous system (CNS\/PNS) manifestations were seen during the SARS-2002, MERS-2012 and COVID-19. However, none of the publication had primary or secondary objectives of searching neurological manifestations in the COVID-19 patients and the pathogenic mechanism which will subsequently strengthen the importance to start more prospective clinical trials. The prevalence of neurological signs and symptoms were taken as primary objective. Thereafter, the prevalence of each CNS\/PNS symptoms was categorized and their prevalence studied. The selection of Bagheri et al., 2020 may be discussed because they have done the cross-sectional study with the neurological finding and correlated the data with prevalence of the COVID-19 positive patients. The proportion of patients presenting with neurological outcome and clinical\/PCR positivity were done. We had searched and followed all the possible online\/web source, still the data collection process may remain a limitation of work due to addition of several publications on COVID-19 every day. Due to lack of data of SARS-CoV and MERS-CoV, we have included the case reports, MERS and COVID-19 in CNS\/PNS manifestations.<\/jats:p>","DOI":"10.1038\/s41598-021-92188-x","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T10:03:33Z","timestamp":1624010613000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["nCoV-2019 infection induced neurological outcome and manifestation, linking its historical ancestor SARS-CoV and MERS-CoV: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"11","author":[{"given":"Ajay","family":"Prakash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phulen","family":"Sarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anusuya","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deba Prasad","family":"Dhibar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeraj","family":"Balaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritu","family":"Shree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Modi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bikash","family":"Medhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"92188_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/ijp.IJP_115_20","volume":"52","author":"M Prajapat","year":"2020","unstructured":"Prajapat, M. et al. Drug targets for corona virus: A systematic review. Indian J Pharmacol 52, 56\u201365. https:\/\/doi.org\/10.4103\/ijp.IJP_115_20 (2020).","journal-title":"Indian J Pharmacol"},{"key":"92188_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5 (2020).","journal-title":"Lancet"},{"key":"92188_CR3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.7326\/M20-0504","volume":"172","author":"SA Lauer","year":"2020","unstructured":"Lauer, S. A. et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application. Ann Intern Med 172, 577\u2013582. https:\/\/doi.org\/10.7326\/M20-0504 (2020).","journal-title":"Ann Intern Med"},{"key":"92188_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2020.04.124","author":"KCNK Kwong","year":"2020","unstructured":"Kwong, K. C. N. K., Mehta, P. R., Shukla, G. & Mehta, A. R. COVID-19, SARS and MERS: A neurological perspective. J Clin Neurosci https:\/\/doi.org\/10.1016\/j.jocn.2020.04.124 (2020).","journal-title":"J Clin Neurosci"},{"key":"92188_CR5","unstructured":"COVID-19 coronavirus pandemic. https:\/\/www.worldometers.info\/coronavirus\/. Assessed 26 May 2020."},{"key":"92188_CR6","unstructured":"WHO. Coronavirus disease (COVID-19) pandemic; 2020. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/events-as-they-happen. Assessed 26 May 2020."},{"key":"92188_CR7","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/jmv.25728","volume":"92","author":"YC Li","year":"2020","unstructured":"Li, Y. C., Bai, W. Z. & Hashikawa, T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 92, 552\u2013555. https:\/\/doi.org\/10.1002\/jmv.25728 (2020).","journal-title":"J Med Virol"},{"key":"92188_CR8","doi-asserted-by":"publisher","first-page":"e102828","DOI":"10.5812\/ircmj.102828","volume":"22","author":"N Karimi","year":"2020","unstructured":"Karimi, N., Sharifi, R. A. & Rouhani, N. Frequent convulsive seizures in an adult patient with COVID-19: A case report. Iran Red Crescent Med J 22, e102828. https:\/\/doi.org\/10.5812\/ircmj.102828 (2020).","journal-title":"Iran Red Crescent Med J"},{"key":"92188_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.chom.2013.03.010","volume":"13","author":"OO Koyuncu","year":"2013","unstructured":"Koyuncu, O. O., Hogue, I. B. & Enquist, L. W. Virus infections in the nervous system. Cell Host Microbe 13, 379\u2013393. https:\/\/doi.org\/10.1016\/j.chom.2013.03.010 (2013).","journal-title":"Cell Host Microbe"},{"key":"92188_CR10","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.23.20041889","author":"SH Bagheri","year":"2020","unstructured":"Bagheri, S. H. et al. Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak. Medrxiv https:\/\/doi.org\/10.1101\/2020.03.23.20041889 (2020).","journal-title":"Medrxiv"},{"key":"92188_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507\u2013513. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7 (2020).","journal-title":"Lancet"},{"key":"92188_CR12","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1056\/NEJMc2008597","volume":"382","author":"J Helms","year":"2020","unstructured":"Helms, J. et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 382, 2268\u20132270. https:\/\/doi.org\/10.1056\/NEJMc2008597 (2020).","journal-title":"N Engl J Med"},{"key":"92188_CR13","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.27.20029009","author":"Y Huang","year":"2020","unstructured":"Huang, Y. et al. Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China. MedRxiv https:\/\/doi.org\/10.1101\/2020.02.27.20029009 (2020).","journal-title":"MedRxiv"},{"key":"92188_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-020-05965-1","author":"JR Lechien","year":"2020","unstructured":"Lechien, J. R. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol https:\/\/doi.org\/10.1007\/s00405-020-05965-1 (2020).","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"92188_CR15","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1127","author":"L Mao","year":"2020","unstructured":"Mao, L. et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. JAMA Neurole https:\/\/doi.org\/10.1001\/jamaneurol.2020.1127 (2020).","journal-title":"JAMA Neurole"},{"key":"92188_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585","author":"D Wang","year":"2020","unstructured":"Wang, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA https:\/\/doi.org\/10.1001\/jama.2020.1585 (2020).","journal-title":"JAMA"},{"key":"92188_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa272(2020)","author":"Z Wang","year":"2020","unstructured":"Wang, Z. et al. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis https:\/\/doi.org\/10.1093\/cid\/ciaa272(2020) (2020).","journal-title":"Clin Infect Dis"},{"key":"92188_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2020.04.024","author":"L Duonga","year":"2020","unstructured":"Duonga, L., Xub, P. & Liua, A. Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles, early April 2020. Brain Behav Immun https:\/\/doi.org\/10.1016\/j.bbi.2020.04.024 (2020).","journal-title":"Brain Behav Immun"},{"key":"92188_CR19","doi-asserted-by":"publisher","first-page":"196","DOI":"10.15537\/smj.2017.2.16255","volume":"38","author":"FM Al-Hameed","year":"2017","unstructured":"Al-Hameed, F. M. Spontaneous intracranial hemorrhage in a patient with Middle East respiratory syndrome corona virus Fahad M. Saudi Med J 38, 196\u2013200. https:\/\/doi.org\/10.15537\/smj.2017.2.16255 (2017).","journal-title":"Saudi Med J"},{"key":"92188_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ijid.2014.09.003","volume":"29","author":"M Saad","year":"2014","unstructured":"Saad, M. et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis 29, 301\u2013306. https:\/\/doi.org\/10.1016\/j.ijid.2014.09.003 (2014).","journal-title":"Int J Infect Dis"},{"key":"92188_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijid.2020.03.062","volume":"94","author":"T Moriguchi","year":"2020","unstructured":"Moriguchi, T. et al. A first case of meningitis\/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 94, 55\u201358. https:\/\/doi.org\/10.1016\/j.ijid.2020.03.062 (2020).","journal-title":"Int J Infect Dis"},{"key":"92188_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25915","author":"A Paniz-Mondolfi","year":"2020","unstructured":"Paniz-Mondolfi, A. et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol https:\/\/doi.org\/10.1002\/jmv.25915 (2020).","journal-title":"J Med Virol"},{"key":"92188_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12382","author":"E Scheidl","year":"2020","unstructured":"Scheidl, E., Canseco, D. D., Hadji-Naumov, A. & Bereznai, B. Guillain-Barr\u00e9 syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature. J Peripher Nerv Syst https:\/\/doi.org\/10.1111\/jns.12382 (2020).","journal-title":"J Peripher Nerv Syst"},{"key":"92188_CR24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jocn.2020.04.062","volume":"76","author":"Z Sedaghat","year":"2020","unstructured":"Sedaghat, Z. & Karimi, N. Guillain Barre syndrome associated with COVID-19 infection: A case report. J Clin Neurosci 76, 233\u2013235. https:\/\/doi.org\/10.1016\/j.jocn.2020.04.062 (2020).","journal-title":"J Clin Neurosci"},{"key":"92188_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51071","author":"S Somani","year":"2020","unstructured":"Somani, S., Pati, S., Gaston, T., Chitlangia, A. & Agnihotri, S. De novo status epilepticus in patients with COVID-19. Ann Clin Transl Neurol https:\/\/doi.org\/10.1002\/acn3.51071 (2020).","journal-title":"Ann Clin Transl Neurol"},{"key":"92188_CR26","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1056\/NEJMc2009191","volume":"382","author":"G Toscano","year":"2020","unstructured":"Toscano, G. et al. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2. N Engl J Med 382, 2574\u20132576. https:\/\/doi.org\/10.1056\/NEJMc2009191 (2020).","journal-title":"N Engl J Med"},{"key":"92188_CR27","doi-asserted-by":"publisher","first-page":"e00771","DOI":"10.1016\/j.idcr.2020.e00771","volume":"20","author":"A Virani","year":"2020","unstructured":"Virani, A. et al. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection. ID Cases 20, e00771. https:\/\/doi.org\/10.1016\/j.idcr.2020.e00771 (2020).","journal-title":"ID Cases"},{"key":"92188_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","volume":"19","author":"H Zhao","year":"2020","unstructured":"Zhao, H., Shen, D., Zhou, H., Liu, J. & Chen, S. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: Causality or coincidence?. Lancet Neurol 19, 383\u2013384. https:\/\/doi.org\/10.1016\/S1474-4422(20)30109-5 (2020).","journal-title":"Lancet Neurol"},{"issue":"12","key":"92188_CR29","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1212\/01.wnl.0000099171.26943.d0","volume":"61","author":"CC Chao","year":"2003","unstructured":"Chao, C. C. et al. Peripheral nerve disease in SARS: Report of a case. Neurology 61(12), 1820\u20131821. https:\/\/doi.org\/10.1212\/01.wnl.0000099171.26943.d0 (2003).","journal-title":"Neurology"},{"key":"92188_CR30","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1373\/clinchem.2003.025437","volume":"49","author":"EC Hung","year":"2003","unstructured":"Hung, E. C. et al. Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem 49, 2108\u20132109. https:\/\/doi.org\/10.1373\/clinchem.2003.025437 (2003).","journal-title":"Clin Chem"},{"key":"92188_CR31","first-page":"26","volume":"15","author":"CS Hwang","year":"2006","unstructured":"Hwang, C. S. Olfactory neuropathy in severe acute respiratory syndrome: Report of a case. Acta Neurol Taiwan 15, 26\u201328 (2006).","journal-title":"Acta Neurol Taiwan"},{"key":"92188_CR32","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3201\/eid1002.030638","volume":"10","author":"KK Lau","year":"2004","unstructured":"Lau, K. K. et al. Possible central nervous system infection by SARS coronavirus. Emerg Infect Dis 10, 342\u2013344. https:\/\/doi.org\/10.3201\/eid1002.030638 (2004).","journal-title":"Emerg Infect Dis"},{"key":"92188_CR33","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s00415-004-0519-8","volume":"251","author":"T Umapathi","year":"2004","unstructured":"Umapathi, T. et al. Large artery ischaemic stroke in severe acute respiratory syndrome (SARS). J Neurol 251, 1227\u20131231. https:\/\/doi.org\/10.1007\/s00415-004-0519-8 (2004).","journal-title":"J Neurol"},{"key":"92188_CR34","doi-asserted-by":"publisher","first-page":"3502683","DOI":"10.1155\/2016\/3502683","volume":"2016","author":"H Algahtani","year":"2016","unstructured":"Algahtani, H., Subahi, A. & Shirah, B. Neurological complications of middle east respiratory syndrome coronavirus: A report of two cases and review of the literature. Case Rep Neurol Med 2016, 3502683. https:\/\/doi.org\/10.1155\/2016\/3502683 (2016).","journal-title":"Case Rep Neurol Med"},{"key":"92188_CR35","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s15010-015-0720-y","volume":"43","author":"YM Arabi","year":"2015","unstructured":"Arabi, Y. M. et al. Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV). Infection 43, 495\u2013501. https:\/\/doi.org\/10.1007\/s15010-015-0720-y (2015).","journal-title":"Infection"},{"key":"92188_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3988\/jcn.2017.13.3.227","volume":"13","author":"JE Kim","year":"2017","unstructured":"Kim, J. E. et al. Neurological complications during treatment of middle east respiratory syndrome. J Clin Neurol 13, 227\u2013233. https:\/\/doi.org\/10.3988\/jcn.2017.13.3.227 (2017).","journal-title":"J Clin Neurol"},{"key":"92188_CR37","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati, A. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. BMJ 339, b2700. https:\/\/doi.org\/10.1136\/bmj.b2700 (2009).","journal-title":"BMJ"},{"key":"92188_CR38","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1001\/archneur.61.11.1669","volume":"61","author":"LK Tsai","year":"2004","unstructured":"Tsai, L. K. et al. Neuromuscular disorders in severe acute respiratory syndrome. Arch Neurol 61, 1669\u20131673. https:\/\/doi.org\/10.1001\/archneur.61.11.1669 (2004).","journal-title":"Arch Neurol"},{"key":"92188_CR39","doi-asserted-by":"publisher","first-page":"116824","DOI":"10.1016\/j.jns.2020.116824","volume":"412","author":"CG Conde","year":"2020","unstructured":"Conde, C. G., Quintana, P. L. D., Quintero, M. I. D., Ramos, V. Y. & Moscote, S. L. R. Neurotropism of SARS-CoV 2: Mechanisms and manifestations. J Neurol Sci 412, 116824. https:\/\/doi.org\/10.1016\/j.jns.2020.116824 (2020).","journal-title":"J Neurol Sci"},{"key":"92188_CR40","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","volume":"118","author":"VB Patel","year":"2016","unstructured":"Patel, V. B., Zhong, J. C., Grant, M. B. & Oudit, G. Y. Role of the ACE2\/Angiotensin 1\u20137 axis of the renin-angiotensin system in heart failure. Circ Res 118, 1313\u20131326. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.307708 (2016).","journal-title":"Circ Res"},{"key":"92188_CR41","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta, P. et al. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033\u20131034. https:\/\/doi.org\/10.1016\/S0140-6736(20)30628-0 (2020).","journal-title":"Lancet"},{"key":"92188_CR42","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3389\/fncel.2018.00386","volume":"12","author":"K Bohmwald","year":"2018","unstructured":"Bohmwald, K., G\u00e1lvez, N. M. S., R\u00edos, M. & Kalergis, A. M. Neurologic alterations due to respiratory virus infections. Front Cell Neurosci 12, 386. https:\/\/doi.org\/10.3389\/fncel.2018.00386 (2018).","journal-title":"Front Cell Neurosci"},{"key":"92188_CR43","first-page":"646","volume":"16","author":"CH Yin","year":"2004","unstructured":"Yin, C. H. et al. Clearance effect of different blood purification techniques on parathyroid hormone in renal function failure patients on maintenance hemodialysis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 16, 646\u2013650 (2004).","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"92188_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/ijp.IJP_119_20","volume":"52","author":"P Sarma","year":"2020","unstructured":"Sarma, P. et al. Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach. Indian J Pharmacol 52, 1\u20135. https:\/\/doi.org\/10.4103\/ijp.IJP_119_20 (2020).","journal-title":"Indian J Pharmacol"},{"key":"92188_CR45","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1212\/WNL.0000000000009619","volume":"95","author":"C Guti\u00e9rrez-Ortiz","year":"2020","unstructured":"Guti\u00e9rrez-Ortiz, C. et al. Miller Fisher Syndrome and polyneuritis cranialis in COVID-19. Neurology 95, 601\u2013605. https:\/\/doi.org\/10.1212\/WNL.0000000000009619 (2020).","journal-title":"Neurology"},{"key":"92188_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25903","author":"J Finsterer","year":"2020","unstructured":"Finsterer, J. & Stollberger, C. Causes of hypogeusia\/hyposmia in SARS-CoV2 infected patients. J Med Virol https:\/\/doi.org\/10.1002\/jmv.25903 (2020).","journal-title":"J Med Virol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92188-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92188-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92188-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T09:53:09Z","timestamp":1670061189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92188-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["92188"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-92188-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]},"assertion":[{"value":"5 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12888"}}